NCT07507175

Brief Summary

The goal of this clinical trial is to determine whether gastrocnemius myofascial release is effective in reducing pain and improving physical function in females with knee osteoarthritis. The main question this study aims to answer are:

  • Does adding gastrocnemius MFR to conventional physical therapy treatment influence pain, physical function, foot posture, and knee disability compared to conventional physical therapy treatment and sham MFR in knee osteoarthritis?
  • Participants receive gastrocnemius myofascial release treatment or sham gastrocnemius myofascial release treatment for 3 times weekly for 4 weeks for both groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
4mo left

Started Jan 2026

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Jan 2026Sep 2026

Study Start

First participant enrolled

January 3, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

7 months

First QC Date

March 19, 2026

Last Update Submit

March 30, 2026

Conditions

Keywords

Knee OsteoarthritisMyofascial releasePhysical functiongastrocnemius

Outcome Measures

Primary Outcomes (1)

  • Pain during rest and single leg squat (Visual analogue scale)

    Participants are instructed to draw a vertical mark on the line indicating their pain level during rest and single leg squat -single leg squat: The Participants stand on the limb being evaluated, with the other leg lifted off the ground so that the hip is flexed to approximately 45 degrees and the knee to approximately 90 degrees. The Participants' shoulders is forward flexed to 90 degrees with the elbows in full extension and the hands clasp together in front. The Participants are forward flexed to squat down until feeling pain and discomfort and return to the start position.

    pain is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

Secondary Outcomes (5)

  • Physical function (40 m fast-paced walk test )

    Physical function is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

  • Physical function (the 30-s chair-stand test)

    Physical function is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

  • Physical function (a stair-climb test )

    Physical function is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

  • Foot posture (foot posture index 6)

    Foot posture is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

  • Knee Disability (Arabic version of Algofunctional index of lequense)

    Knee Disability is measured at baseline at the first session and reassessed at the end of the second week, and at the end of four weeks.

Study Arms (2)

GASTROCNEMIUS MYOFASCIAL RELEASE

EXPERIMENTAL

GM MFR and TrP pressure release with a combination of manual physical therapy (knee mobilization), supervised exercise (riding a stationary bike, muscle strengthening exercises for the hip and knee, and self-stretching of lower limb muscles), and TENS

Procedure: GASTROCNEMIUS MYOFASCIAL RELEASE

sham GASTROCNEMIUS MYOFASCIAL RELEASE

SHAM COMPARATOR

sham GM MFR with a combination of manual physical therapy (knee mobilization), supervised exercise (riding a stationary bike, muscle strengthening exercises for the hip and knee, and self-stretching of lower limb muscles), and TENS

Procedure: sham Gastrocnemius MYOFASCIAL RELEASE

Interventions

Gastrocnemius MFR Procedures : * Technique 1: With the elbow flexed to 90◦ and take up a contact in the Tendo Achilles. Establish a line of tension in a superior direction. * Technique 2: with the index and middle fingers of each hand to take up a contact on the tendons of the GM at the epicondyles of the femur. Establish a line of tension in an inferior direction. * Technique 3: With the index, middle and ring fingers of each hand to get into the medial and lateral aspects of the calcaneus . The release begins proximally. * (5 minutes× 1 repetition) for the three technique * Gastrocnemius TrP pressure release is repeated for 90 seconds (usually 3 repetitions). * Anterior glide \& Posterior glide (grade IV) * Riding a stationary bike for 5 minutes * Quadriceps set exercise * Terminal knee extension * Step-up exercises for 30 seconds * Lateral Step-up for 30 seconds. * Self-stretching of Hamstring, Rectus femoris ,and Calf muscles. * TENS for 20 minutes

Also known as: Gastrocnemius MFR
GASTROCNEMIUS MYOFASCIAL RELEASE

Patient position: Prone, with feet off the end of the table to allow for adequate dorsiflexion. Therapist's position:, facing toward the feet while standing at the patient's side, at around mid-thigh level for techniques. Technique: one hand is positioned at the attachments of the GM at the epicondyles of the femur, and the other at the Achilles tendon without applying significant pressure or tissue deformation. Mimic the hand movements of real myofascial release (e.g., slow stroking, superficial gliding) but avoid: Deep pressure, Skin stretch, and Muscle compression. * Anterior glide \& Posterior glide (grade IV) * Riding a stationary bike for 5 minutes * Quadriceps set exercise * Terminal knee extension * Step-up exercises for 30 seconds * Lateral Step-up for 30 seconds. * Self-stretching of Hamstring, Rectus femoris ,and Calf muscles. * TENS for 20 minutes

Also known as: Placebo Gastrocnemius Myofascial Release
sham GASTROCNEMIUS MYOFASCIAL RELEASE

Eligibility Criteria

Age45 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients' ages ranged between 45 and 55 years .
  • BMI ≤35
  • Patients with a diagnosis of primary KOA according to the American College of Rheumatology classification at the screening visit .
  • Onset of symptomatic knee osteoarthritis of ≥3 months
  • Patients with grade II and III OA of the Kellgren and Lawrence system for classification of osteoarthritis .
  • At least one active trigger point in GM
  • If both knees were diagnosed as OA, the most affected one was selected.
  • Current pain intensity on the Visual Analogue Scale (VAS) ≥4/10.
  • Subjects have sufficient cognition that enables them to understand the requirements of the study, comply with the study procedures, and visit schedule.
  • Diagnostic Criteria of KOA
  • A diagnosis of knee osteoarthritis was made when knee pain is present, plus Osteophytes on radiographs, plus at least 1 of the following 3:
  • Age \> 50 years
  • Morning stiffness \< 30 minutes
  • Crepitus on active motion

You may not qualify if:

  • Patients with any previous knee surgeries or lower limb fractures.
  • Chronic inflammatory diseases such as rheumatoid arthritis.
  • Signs of moderately significant knee synovitis include a warm and swollen (red) knee
  • History and/or physical examination findings compatible with knee internal derangement (e.g, positive Thessaly test).
  • Pregnancy
  • Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months .
  • Use of NSAIDs one week before the screening visit .
  • Orthopedic diseases, or congenital musculoskeletal deformities, or neurological disorders that may affect or interfere with the therapeutic effect.
  • Participated in other intervention studies (strength training program or physiotherapy treatment for knee osteoarthritis) in the current period and the past 6 months .
  • Habitual use of psychotropic or narcotic analgesics for ≥1 week within 8 weeks prior to screening .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Cairo University

Giza, Giza Governorate, 12613, Egypt

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Central Study Contacts

Hend Hammam Soliman, Bachelor's Degree

CONTACT

Afaf Omar Tahoon

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's Student, Faculty of Physical Therapy, Cairo University

Study Record Dates

First Submitted

March 19, 2026

First Posted

April 2, 2026

Study Start

January 3, 2026

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations